Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fu

Showing results (71-80 of 205) with videos related to

Pageof 21
Sort By:
European Journal of Heart Failure|May 28, 2014
Trends in prevalence from 1990 to 2007 of patients hospitalized with heart failure in SwedenPär Parén, Maria Schaufelberger, Lena Björck, et al.
International Journal of Cardiology|November 22, 2007
Characteristics of heart failure in the elderly--a hospital cohort registry-based studyJuliana Jensen, Linda Hedin, Charlotte Widell, et al.
European Journal of Heart Failure|January 20, 2010
Rationale and design of the beta-blocker in heart failure with normal left ventricular ejection fraction (beta-PRESERVE) studyJingmin Zhou, Haiming Shi, Jian Zhang, et al.
ESC Heart Failure|January 8, 2020
Prognostic impact over time of ischaemic heart disease vs. non-ischaemic heart disease in heart failureJonas Silverdal, Helen Sjöland, Entela Bollano, et al.
International Journal of Cardiology|January 26, 2024
Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysisYu Kang, Nan Qu, Zhongyin Zhang, et al.
ESC Heart Failure|February 8, 2022
Prognostic differences in long-standing vs. recent-onset dilated cardiomyopathyJonas Silverdal, Helen Sjöland, Aldina Pivodic, et al.
ESC Heart Failure|July 31, 2020
Trends in cause-specific readmissions in heart failure with preserved vs. reduced and mid-range ejection fractionXiaotong Cui, Erik Thunström, Ulf Dahlström, et al.
Journal of the American Heart Association|September 30, 2025
Increased Mortality and Morbidity in Patients With Heart Failure With Sarcoidosis Compared With Other Causes: A Propensity-Matched Nationwide Cohort StudyEntela Bollano, Michael Fu, Aldina Pivodic, et al.
Lakartidningen|September 30, 2021
[SCORE2 - an updated model for cardiovascular risk prediction]Mattias Brunström, Jonas Andersson, Mats Eliasson, et al.
Scientific Reports|July 2, 2021
Incremental changes in QRS duration as predictor for cardiovascular disease: a 21-year follow-up of a randomly selected general populationXiaojing Chen, Per-Olof Hansson, Erik Thunström, et al.
Pageof 21

Showing results (71-80 of 205) with videos related to

Sort By:
Pageof 21
European Journal of Heart Failure|May 28, 2014
Trends in prevalence from 1990 to 2007 of patients hospitalized with heart failure in SwedenPär Parén, Maria Schaufelberger, Lena Björck, et al.
International Journal of Cardiology|November 22, 2007
Characteristics of heart failure in the elderly--a hospital cohort registry-based studyJuliana Jensen, Linda Hedin, Charlotte Widell, et al.
European Journal of Heart Failure|January 20, 2010
Rationale and design of the beta-blocker in heart failure with normal left ventricular ejection fraction (beta-PRESERVE) studyJingmin Zhou, Haiming Shi, Jian Zhang, et al.
ESC Heart Failure|January 8, 2020
Prognostic impact over time of ischaemic heart disease vs. non-ischaemic heart disease in heart failureJonas Silverdal, Helen Sjöland, Entela Bollano, et al.
International Journal of Cardiology|January 26, 2024
Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: A systematic review and meta-analysisYu Kang, Nan Qu, Zhongyin Zhang, et al.
ESC Heart Failure|February 8, 2022
Prognostic differences in long-standing vs. recent-onset dilated cardiomyopathyJonas Silverdal, Helen Sjöland, Aldina Pivodic, et al.
ESC Heart Failure|July 31, 2020
Trends in cause-specific readmissions in heart failure with preserved vs. reduced and mid-range ejection fractionXiaotong Cui, Erik Thunström, Ulf Dahlström, et al.
Journal of the American Heart Association|September 30, 2025
Increased Mortality and Morbidity in Patients With Heart Failure With Sarcoidosis Compared With Other Causes: A Propensity-Matched Nationwide Cohort StudyEntela Bollano, Michael Fu, Aldina Pivodic, et al.
Lakartidningen|September 30, 2021
[SCORE2 - an updated model for cardiovascular risk prediction]Mattias Brunström, Jonas Andersson, Mats Eliasson, et al.
Scientific Reports|July 2, 2021
Incremental changes in QRS duration as predictor for cardiovascular disease: a 21-year follow-up of a randomly selected general populationXiaojing Chen, Per-Olof Hansson, Erik Thunström, et al.
Pageof 21